StockTipsArenaBeta

Glenmark PharmaceuticalsShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,437.2-21.80 (-0.89%)
As of 4 Sept 2026
Analysts lean BUY·3 of 4 long-term calls BUY·consensus 1Y target ₹2,352.5 (3.5% below CMP)
₹2,352.5
3.5% below CMP
₹1,640 – ₹2,610
4 active 1Y targets
7 open
6 BUY · 1 SELL (all horizons)
36%
25 of 69 closed calls hit
Watch GLENMARK for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (78) · loading…

BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI7+·2−+8.9% P&L+6.3% upside left
₹2,437.2
CMP
Entry*
₹2,238
Target
₹2,590
HSHSBC Securities· via CNBC Awaaz.4w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI7+·2−+9.3% P&L+5.4% upside left
₹2,437.2
CMP
Entry*
₹2,230
Target
₹2,570
MOMotilal Oswal· via Institutional / Brokerage Research4w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI7+·2−+10.7% P&L+7.1% upside left
₹2,437.2
CMP
Entry*
₹2,201.2
Target
₹2,610
MOMotilal Oswal· via Institutional / Brokerage Research13w ago
SELLGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI1+·7−-24.7% P&L+32.7% upside left
₹2,437.2
CMP
Target
₹1,640
Entry*
₹1,954.2
ISICICI Securities· via Institutional / Brokerage Research30w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.64% realised0.0% upside left
Entry*
₹1,920.4
Target
₹2,240
hit 11 Mar 2026, 12:03 pm
MOMotilal Oswal· via Institutional / Brokerage Research30w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+23.07% realised0.0% upside left
Entry*
₹1,868.9
Target
₹2,300
hit 23 Apr 2026, 12:04 pm
DCDeven Choksey, DRChoksey· via Institutional / Brokerage Research41w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.11% realised0.0% upside left
Entry*
₹1,868.9
Target
₹2,170
hit 10 Mar 2026, 12:03 pm
MOMotilal Oswal· via Institutional / Brokerage Research41w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.87% realised0.0% upside left
Entry*
₹1,918.8
Target
₹2,300
hit 23 Apr 2026, 12:04 pm
DCDeven Choksey, DRChoksey· via Institutional / Brokerage Research52w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.59% realised0.0% upside left
Entry*
₹1,973.9
Target
₹2,400
hit 28 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research54w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+11.41% realised0.0% upside left
Entry*
₹2,181.1
Target
₹2,430
hit 29 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research60w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.57% realised0.0% upside left
Entry*
₹1,390.1
Target
₹1,690
hit 23 Jun 2025, 12:00 am
MOMotilal Oswal· via Institutional / Brokerage Research66w ago
SELLGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI0+·1−+14.10% realised0.0% upside left
Target
₹1,345
Entry*
₹1,565.8
hit 14 Feb 2025, 12:02 pm
ISICICI Securities· via Institutional / Brokerage Research107w ago
BUYGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI0+·1−+18.15% realised0.0% upside left
Entry*
₹1,565.8
Target
₹1,850
hit 7 Jul 2025, 12:07 pm
MOMotilal Oswal· via Institutional / Brokerage Research107w ago
SELLGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·10−-15.45% realisedNA upside left
₹2,246.5
At expiry
Target
₹1,570
Entry*
₹1,945.8
expired 19 Aug 2026, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research54w ago
SELLGLENMARKGlenmark Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI0+·3−-0.45% realisedNA upside left
₹2,235.5
At expiry
Target
₹1,620
Entry*
₹2,225.5
expired 17 Jul 2026, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research59w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI7+·2−+4.6% P&L+6.3% upside left
₹2,437.2
CMP
Entry*
₹2,331
Target
₹2,590
CBChoice Broking· via Economic Times Stock Recos Overview2w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 Months
AI7+·2−+11.8% P&L0.0% upside left
₹2,437.2
CMP
SL
₹2,140
Entry
₹2,180
Target
₹2,380
RSRahul Sharma, JM Financial· via CNBC Awaaz.9w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)Target hit
AI7+·3−+4.95% realised0.0% upside left
SL
₹2,325
Entry*
₹2,391.7
Target
₹2,510
hit 28 Aug 2026, 12:08 pm
KBKush Bohra· via NDTV Profit1w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 MonthsTarget hit
AI10+·2−+5.87% realised0.0% upside left
Entry*
₹2,267
Target
₹2,400
hit 25 Aug 2026, 12:08 pm
OKOsho Krishan, Angel One· via ET Now8w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 MonthsTarget hit
+7.07% realised0.0% upside left
SL
₹2,196
Entry*
₹2,241.6
Target
₹2,400
hit 28 Apr 2026, 12:04 pm
SGSachin Gupta· via CNBC Awaaz.19w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI10+·2−-1.74% realisedNA upside left
SL
₹2,260
Entry
₹2,300
Target
₹2,420
hit 19 Aug 2026, 12:08 pm
MJManas Jaiswal· via CNBC Awaaz.3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI10+·2−-1.43% realisedNA upside left
SL
₹2,245
Entry*
₹2,277.6
Target
₹2,350
hit 11 Aug 2026, 12:08 pm
RPRajesh Palviya, Axis Securities· via CNBC Awaaz.4w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 MonthsStop-loss hit
-2.39% realisedNA upside left
SL
₹2,161
Entry
₹2,214
Target
₹2,320
hit 24 Jun 2026, 12:06 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram10w ago
BUYGLENMARKGlenmark Pharmaceuticals1–3 MonthsStop-loss hit
-4.77% realisedNA upside left
SL
₹2,030
Entry*
₹2,131.7
Target
₹2,300
hit 2 Apr 2026, 12:04 pm
RJRuchit Jain, Motilal Oswal· via ET Now22w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI4+·0−— P&L0.0% upside left
₹2,437.2
CMP
SL
₹2,150
Target
₹2,200
PGPrakash Gaba· via CNBC Awaaz.2d ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 WeeksTarget hit
AI4+·1−+1.83% realised0.0% upside left
Entry*
₹2,455
Target
₹2,500
hit 28 Aug 2026, 2:00 pm
RVRachna Vaidya· via CNBC Awaaz.1w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·0−+2.42% realised0.0% upside left
SL
₹2,360
Entry*
₹2,392.2
Target
₹2,450
hit 26 Aug 2026, 10:00 am
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.1w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·1−+1.19% realised0.0% upside left
SL
₹2,355
Entry*
₹2,371.7
Target
₹2,400
hit 25 Aug 2026, 9:15 am
PGPrakash Gaba· via CNBC Awaaz.1w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·1−+3.57% realised0.0% upside left
SL
₹2,330
Entry*
₹2,365.5
Target
₹2,450
hit 26 Aug 2026, 10:00 am
NCNeerav Chheda, Nirmal Bang Securities· via Zee Business (Live)1w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·1−+6.52% realised0.0% upside left
SL
₹2,260
Entry*
₹2,318.8
Target
₹2,470
hit 27 Aug 2026, 9:20 am
CTChandan Taparia, Motilal Oswal· via LiveMint Markets2w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·1−+3.66% realised0.0% upside left
SL
₹2,280
Entry*
₹2,334.6
Target
₹2,420
hit 26 Aug 2026, 9:20 am
SCShrikant Chouhan, Kotak Securities· via Zee Business (Live)2w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI7+·1−+0.86% realised0.0% upside left
SL
₹2,300
Entry*
₹2,320
Target
₹2,340
hit 14 Aug 2026, 10:30 am
PGPrakash Gaba· via CNBC Awaaz.3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI8+·2−+2.41% realised0.0% upside left
SL
₹2,265
Entry*
₹2,285
Target
₹2,340
hit 14 Aug 2026, 10:30 am
SRSiddharth Rai Mangala· via Zee Business (Live)3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·1−+1.35% realised0.0% upside left
SL
₹2,150
Entry*
₹2,220
Target
₹2,250
hit 29 Jul 2026, 1:15 pm
PGPrakash Gaba· via CNBC Awaaz.6w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
+4.76% realised0.0% upside left
SL
₹2,150
Entry
₹2,205
Target
₹2,310
hit 23 Apr 2026, 9:50 am
NSNagaraj Shetty, HDFC Securities· via ET Now20w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
+5.19% realised0.0% upside left
Entry
₹2,120
Target
₹2,230
hit 1 Apr 2026, 9:25 am
CTChandan Taparia, Motilal Oswal· via ET Now22w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·1−-1.05% realisedNA upside left
SL
₹2,310
Entry*
₹2,334.6
Target
₹2,390
hit 21 Aug 2026, 9:30 am
RPRajesh Palviya, Axis Securities· via ET Now2w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·1−-0.20% realisedNA upside left
SL
₹2,325
Entry*
₹2,329.7
Target
₹2,400
hit 17 Aug 2026, 9:20 am
PGPrakash Gaba· via CNBC Awaaz.2w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI7+·2−-1.73% realisedNA upside left
SL
₹2,275
Entry*
₹2,315
Target
₹2,360
hit 19 Aug 2026, 9:40 am
RPRajesh Palviya, Axis Securities· via ET Now (Live)3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI7+·1−-0.86% realisedNA upside left
SL
₹2,300
Entry*
₹2,320
Target
₹2,350
hit 17 Aug 2026, 11:10 am
PGPrakash Gaba· via CNBC Awaaz.3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI7+·2−-3.04% realisedNA upside left
SL
₹2,230
Entry
₹2,300
Target
₹2,400
hit 19 Aug 2026, 10:55 am
RPRajesh Palviya, Axis Securities· via ET Now (Live)3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI8+·2−-1.74% realisedNA upside left
SL
₹2,260
Entry
₹2,300
Target
₹2,425
hit 19 Aug 2026, 10:45 am
ASAmit Seth· via CNBC Awaaz.3w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·2−-1.00% realisedNA upside left
SL
₹2,270
Entry*
₹2,293
Target
₹2,340
hit 10 Aug 2026, 11:00 am
RPRajesh Palviya, Axis Securities· via CNBC Awaaz.4w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·1−-2.21% realisedNA upside left
SL
₹2,220
Entry*
₹2,270.2
Target
₹2,350
hit 30 Jul 2026, 12:25 pm
RPRajesh Palviya, Axis Securities· via Business Today5w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI7+·1−-3.61% realisedNA upside left
SL
₹2,180
Entry*
₹2,261.7
Target
₹2,420
hit 3 Aug 2026, 9:40 am
AMAjit Mishra, Religare· via Business Standard Markets5w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-1.23% realisedNA upside left
SL
₹2,240
Entry*
₹2,268
Target
₹2,300
hit 8 Jul 2026, 2:00 pm
PGPrakash Gaba· via CNBC Awaaz.8w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-2.76% realisedNA upside left
SL
₹2,160
Entry*
₹2,221.2
Target
₹2,300
hit 24 Jun 2026, 11:30 am
SMSomil Mehta, Sharekhan· via CNBC Awaaz.10w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-3.38% realisedNA upside left
SL
₹2,290
Entry
₹2,370
Target
₹2,580
hit 22 May 2026, 12:00 pm
LSLaxmikant Shukla, YES Securities· via ET Now15w ago
BUYGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-5.98% realisedNA upside left
SL
₹2,200
Entry*
₹2,339.9
Target
₹2,600
hit 1 Jun 2026, 9:35 am
VPVaishali Parekh, Prabhudas Lilladher· via Business Today15w ago
SELLGLENMARKGlenmark Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·8−-2.62% realisedNA upside left
₹2,332.9
At expiry
Target
₹2,150
Entry*
₹2,273.3
expired 20 Aug 2026, 3:30 pm
PGPrakash Gaba· via CNBC Awaaz.4w ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.